Companies · Other Health Care

KH Acquisition, LLC

SKOKIE · Other Health Care

Diligence memoA one-page analyst read on KH Acquisition, LLC — recommendation, valuation, rhythm, risks.
$188.5M
Total raised · real
4
Rounds
0.1×
Latest step-up
Top 3%
Sector rank · raised
Series D+
Latest stage · inferred · Wed Jul 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)

KH Acquisition, LLC looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.00× the median modeled value of Series D+ Other Health Care companies in 2013–2015 (16 peers) — value vs value, same stage and era.
Dormant
  • Last raise 11.0 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

KH Acquisition, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
11.5 yr record
Peak capital year was 2014 with $184.0M across 1 filings.
Market position
ahead of 98% of Other Health Care peers
Capital scale is ahead of 98% of Other Health Care peers; modeled value is above 23% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2014: $184.0M across 1 filings.
  • Largest single filing was $184.0M on 2014-12-31.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

KH Acquisition, LLC is one of 5377 Other Health Care companies tracked from SKOKIE. By capital raised it ranks among the largest (ahead of 98% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$1.3B$2.5B$3.8B$5.0BSeries D+ · 2014-12-31 Raised $184M (real) Modeled valuation $4.2B (est)$184M$4.2BSeries D+2014Series D+ · 2015-01-31 Raised $1.1M (real) Modeled valuation $24M (est)$1.1M$24MSeries D+2015Series D+ · 2015-02-20 Raised $3.2M (real) Modeled valuation $74M (est)$3.2M$74MSeries D+2015Series D+ · 2015-07-01 Raised $250K (real) Modeled valuation $5.8M (est)$250K$5.8MSeries D+2015+$1.1M+$3.2M+$250KCumulative $189M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series D+$184.0M · 2014
Series D+ extension$1.1M · 2015
Series D+ extension$3.2M · 2015
Series D+ extension$250K · 2015

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B, Series C — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 17%.

Modeled valuation trajectory
$5.8M
Base estimate est.
$1.3M
Conservative case
$12.6M
Upside case
$2.1M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series D+a $100M–$400M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series D+ · modeled $4.2B · 2014-12-312014Series D+ · modeled $24.3M · 2015-01-31Series D+ · modeled $74.2M · 2015-02-20Series D+ · modeled $5.8M · 2015-07-012015
Model inputs · modeled:benchmark-stage-stepup-v1
12%
Dilution assumption
Implied ownership sold in the financing.
80%
Survival probability
64% low · 88% high
1.23×/yr
Annual markup
1.38×/yr upside case
6.0 yr
Elapsed time used
11.0 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
2 mo
Avg between rounds
$378.4M/yr
Capital velocity
11.5 yr
On record since
2014
First round
4
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 78× above median
This company$188.5M
Sector median$2.4M
Latest round — vs other Series D+ rounds in sector (real $, this stage) 0.0× of median
This company$250K
Sector median$123.0M
Modeled value — vs sector median (estimate, all stages) 0.3× of median
This company$5.8M
Sector median$22.1M

Raised more than 98% of sector peers (real $). Modeled value above 23% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series D+) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #16 of 16.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0B$10.0B$100.0B$10.0M$100.0M$1.0BCapital raised (log)Onex TSG Holdings Corp. · Series D+ Raised $336.0M · modeled $7.7B (est)BVO Holdings, LLC · Series D+ Raised $335.8M · modeled $7.7B (est)Mdp Hc Holdings, Llc · Series D+ Raised $310.1M · modeled $7.1B (est)Amsurg Corp · Series D+ Raised $270.9M · modeled $6.2B (est)Greatbatch, Inc. · Series D+ Raised $247.2M · modeled $5.7B (est)Hc Group Holdings Iii, Inc. · Series D+ Raised $144.3M · modeled $3.3B (est)Diplomat Pharmacy, Inc. · Series D+ Raised $140.0M · modeled $3.2B (est)Proteus Biomedical Inc · Series D+ Raised $162.4M · modeled $2.7B (est)Mmi Holdings Inc · Series D+ Raised $109.0M · modeled $2.5B (est)Evolent Health LLC · Series D+ Raised $221.3M · modeled $2.3B (est)BioScrip, Inc. · Series D+ Raised $172.5M · modeled $1.4B (est)Envision Rx Options Holdings, Inc. · Series D+ Raised $144.5M · modeled $80.0M (est)KH Acquisition, LLC (this company) Raised $188.5M · modeled $5.8M (est)KH Acquisition, LLC
CompanyStageRaised · realValue · estvs peer med.
Onex TSG Holdings Corp.Series D+$336.0M$7.7B2.94×
BVO Holdings, LLCSeries D+$335.8M$7.7B2.94×
Mdp Hc Holdings, LlcSeries D+$310.1M$7.1B2.71×
Amsurg CorpSeries D+$270.9M$6.2B2.37×
Greatbatch, Inc.Series D+$247.2M$5.7B2.16×
Hc Group Holdings Iii, Inc.Series D+$144.3M$3.3B1.26×
Diplomat Pharmacy, Inc.Series D+$140.0M$3.2B1.23×
Proteus Biomedical IncSeries D+$162.4M$2.7B1.05×
Mmi Holdings IncSeries D+$109.0M$2.5B0.95×
Evolent Health LLCSeries D+$221.3M$2.3B0.89×
BioScrip, Inc.Series D+$172.5M$1.4B0.55×
Envision Rx Options Holdings, Inc.Series D+$144.5M$80.0M0.03×
KH Acquisition, LLC this companySeries D+$188.5M$5.8M0.00×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series D+$184.0M2014-12-31$1.5B$4.2B90%
Series D+$1.1M2015-01-31$8.8M$24.3M90%
Series D+$3.2M2015-02-20$26.9M$74.2M90%
Series D+$250K2015-07-01$2.1M$5.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series D+$184.0M2014-12-31
    • First recorded raise — entered as Series D+.
  2. Series D+$1.1M2015-01-31
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 174.5× smaller than the prior — bridge or down round.
  3. Series D+$3.2M2015-02-20
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 3.1× larger than the prior — scaling up.
  4. Series D+$250K2015-07-01
    • Came back fast: 4 mo vs the ~14 mo sector norm.
    • Round 12.9× smaller than the prior — bridge or down round.
Intelligence
2015 ~Q3
Modeled next raise · ~2mo cadence
$250K
Modeled next size est.range $250K$400K
0.1×
Last step-up
$378.4M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Timothy Sullivan15 other2014-12
MATTHEW NORTON1 other2014-12
T. JASON SHIDELER1 other2014-12
ANDREW JASON MAJKA2014-12
ANU JASON SINGH2015-07
CATHERINE JASON GUELICH2014-12
DANIEL JASON MAJKA2015-07
DAVID JASON CYGANOWSKI2014-12
ERIC JASON JORDAHL2014-12
EUGENE JASON SUNSHINE2015-07
JAMES JASON BLAKE2014-12
JAMES JASON PIZZO2014-12
JASON JASON SUSSMAN2014-12
JODY JASON MILL-MISCHEL2014-12
KENNETH KAUFMAN2014-12
KEVIN JASON COSTELLO2015-07
KIT JASON KAMHOLZ2014-12
MARK JASON GRUBE2014-12
MICHAEL JASON FINNERTY2014-12
PATRICK JASON ALLEN2015-07
ROBERT JASON ZELLER2014-12
RYAN JASON GISH2014-12
SANDY JASON NUCCIO2014-12
THERESE JASON WAREHAM2014-12
Registry & provenance

KH Acquisition, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1630406
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Mdp Hc Holdings, LlcOther Health CareSeries D+$310.1M$7.1Bnetwork1 shared operator · same sector · same stage
Sage Products Holdings, LLCOther Health CareGrowth/Late$522.5M$12.4Bnetwork1 shared operator · same sector
Mdp Acm Holdings, LlcOther Health CareSeries C$60.0M$1.4Bnetwork1 shared operator · same sector
Hc Group Holdings I, LlcOther Health CareGrowth/Late$607.4M$14.4Bnetwork1 shared operator · same sector
Envoy Medical CorpOther Health CareSeries B$56.8M$6.7Msame sector
RT Oncology Services CorpOther Health CareSeries B$56.5M$5.0Msame sector
HeartWare International, Inc.Other Health CareSeries C$55.2M$5.0Msame sector
CLEARFLOW, IncOther Health CareSeries A$51.4M$6.8Msame sector
Frequently asked
How much funding has KH Acquisition, LLC raised?
KH Acquisition, LLC has raised approximately $188.5M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is KH Acquisition, LLC's estimated valuation?
Provath's modeled valuation for KH Acquisition, LLC is approximately $5.8M (modeled range $1.3M–$12.6M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is KH Acquisition, LLC at?
KH Acquisition, LLC's latest modeled financing stage is Series D+. Its most recent recorded round closed around Wed Jul 01.
What does KH Acquisition, LLC do and where is it based?
KH Acquisition, LLC operates in the Other Health Care sector, based in SKOKIE.
Explore related

See where KH Acquisition, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at KH Acquisition, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.